Featured Platforms
  


Custom Protein Generation

Mammalian- Derived Products

Microbial- Derived Products

Antibody Drug Conjugates

Bispecific Ab Platform

Technologies & Platforms

 

CRISPR/Cas9 Gene Editing Services

CRISPR/Cas9 is a powerful, time-saving molecular biology tool that can be applied to a wide variety of applications within vaccine or biotherapeutic discovery and product development. WuXi Biologics has taken a research license of CRISPR/Cas9 technologies from the Broad Institute for use in biologics and vaccine research and development. Whether changing the glycan profiles of monoclonal antibodies or optimizing cellular protein expression in a producer cell line, the utility of CRISPR is vast and our team of experts can help you determine if the use of CRISPR is right for your product and project needs.

Applying CRISPR technology to enhance your drug development efforts

Applications for CRISPR gene editing that can be applied to producer cell lines or other protein expression systems to improve cell growth, productivity, product titer and product quality include but are not limited to:

  • Post-translational modifications of protein product
  • Metabolic engineering (e.g., knockout fucose glycosylation)
  • Engineering cells for hypothermic growth
  • Regulating apoptosis in cells
  • Regulating cell cycle progression
  • Engineering of chaperones and foldases
shutterstock_1103833505-min
shutterstock_1179311575-min
 

Our highly trained scientists can provide customized advice and services for a wide variety of gene editing functions

  • Microbial or mammalian cell genome editing services
  • DNA or RNA editing
  • Transcription activation or repression
  • Gene editing of mAbs, Fc-fusion proteins, enzymes, bispecific Abs, plasmids and a wide range of viral vaccine or gene therapy vectors
  • Zero-footprint CRISPR knockout and knockin using non-integrated sgRNA and Cas9
  • Inducible gene activation and inhibition with CRISPRa and CRISPRi
  • Reporter cells and other non-CRISPR mediated engineering available
BACK